246 related articles for article (PubMed ID: 31083325)
1. Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target.
Chu PY; Tai YL; Shen TL
Cells; 2019 May; 8(5):. PubMed ID: 31083325
[TBL] [Abstract][Full Text] [Related]
2. Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy.
Villalobo A; García-Palmero I; Stateva SR; Jellali K
J Pharm Pharm Sci; 2013; 16(2):177-89. PubMed ID: 23958188
[TBL] [Abstract][Full Text] [Related]
3. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Nadler Y; González AM; Camp RL; Rimm DL; Kluger HM; Kluger Y
Ann Oncol; 2010 Mar; 21(3):466-473. PubMed ID: 19717535
[TBL] [Abstract][Full Text] [Related]
4. EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells.
Chu PY; Li TK; Ding ST; Lai IR; Shen TL
J Biol Chem; 2010 Sep; 285(38):29279-85. PubMed ID: 20622016
[TBL] [Abstract][Full Text] [Related]
5. Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain.
Spuches AM; Argiros HJ; Lee KH; Haas LL; Pero SC; Krag DN; Roller PP; Wilcox DE; Lyons BA
J Mol Recognit; 2007; 20(4):245-52. PubMed ID: 17705331
[TBL] [Abstract][Full Text] [Related]
6. GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling.
Luoh SW; Wagoner W; Wang X; Hu Z; Lai X; Chin K; Sears R; Ramsey E
Mol Carcinog; 2019 May; 58(5):699-707. PubMed ID: 30604896
[TBL] [Abstract][Full Text] [Related]
7. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma.
Gotovac JR; Liu DS; Yates MJ; Milne JV; Macpherson AA; Simpson KJ; Eslick GD; Mitchell C; Duong CP; Phillips WA; Clemons NJ
J Pathol; 2020 Nov; 252(3):317-329. PubMed ID: 32737994
[TBL] [Abstract][Full Text] [Related]
8. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.
Wang Y; Chan DW; Liu VW; Chiu P; Ngan HY
Clin Cancer Res; 2010 May; 16(9):2529-39. PubMed ID: 20388850
[TBL] [Abstract][Full Text] [Related]
9. The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.
Pias S; Peterson TA; Johnson DL; Lyons BA
Crit Rev Immunol; 2010; 30(3):299-304. PubMed ID: 20370637
[TBL] [Abstract][Full Text] [Related]
10. Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target.
Watson GM; Kulkarni K; Sang J; Ma X; Gunzburg MJ; Perlmutter P; Wilce MCJ; Wilce JA
J Med Chem; 2017 Nov; 60(22):9349-9359. PubMed ID: 29083893
[TBL] [Abstract][Full Text] [Related]
11. Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1.
Qian L; Bradford AM; Cooke PH; Lyons BA
J Mol Recognit; 2016 Jul; 29(7):318-33. PubMed ID: 26869103
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression.
Ambaye ND; Pero SC; Gunzburg MJ; Yap M; Clayton DJ; Del Borgo MP; Perlmutter P; Aguilar MI; Shukla GS; Peletskaya E; Cookson MM; Krag DN; Wilce MC; Wilce JA
J Mol Biol; 2011 Sep; 412(3):397-411. PubMed ID: 21802427
[TBL] [Abstract][Full Text] [Related]
13. Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines.
Lim RC; Price JT; Wilce JA
Breast Cancer Res Treat; 2014 Feb; 143(3):593-603. PubMed ID: 24464577
[TBL] [Abstract][Full Text] [Related]
14. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
[TBL] [Abstract][Full Text] [Related]
15. Grb7-based molecular therapeutics in cancer.
Pero SC; Daly RJ; Krag DN
Expert Rev Mol Med; 2003 May; 5(14):1-11. PubMed ID: 14585167
[TBL] [Abstract][Full Text] [Related]
16. Grb7 and Filamin-a associate and are colocalized to cell membrane ruffles upon EGF stimulation.
Paudyal P; Shrestha S; Madanayake T; Shuster CB; Rohrschneider LR; Rowland A; Lyons BA
J Mol Recognit; 2013 Nov; 26(11):532-41. PubMed ID: 24089360
[TBL] [Abstract][Full Text] [Related]
17. Dimerization in the Grb7 protein.
Peterson TA; Benallie RL; Bradford AM; Pias SC; Yazzie J; Lor SN; Haulsee ZM; Park CK; Johnson DL; Rohrschneider LR; Spuches A; Lyons BA
J Mol Recognit; 2012 Aug; 25(8):427-34. PubMed ID: 22811067
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma.
Tanaka S; Mori M; Akiyoshi T; Tanaka Y; Mafune K; Wands JR; Sugimachi K
Cancer Res; 1997 Jan; 57(1):28-31. PubMed ID: 8988034
[TBL] [Abstract][Full Text] [Related]
19. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
20. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
